Rare lephants

Screener

C

C21 Investments Inc.

CWLXF ·Healthcare, Drug Manufacturers - General

Financial Statements
Profitability
Balance Sheet
Cash Flow
Share-Based Metrics
Valuation

Profit History
Profit Flow
Profit Margins
Returns on Capital

Profitability › Returns on Capital

Annual Quarterly

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Fiscal Year	ROE	ROI	ROA
FY2025	-13.8%	-13.8%	-7.0%
FY2026	-12.8%	-12.8%	-6.0%

Rare lephants

Fundamental stock research — financial statements, interactive charts, a stock screener, valuation tools, and moat scoring, all in one place.

Support

If you find RareElephants useful, please consider donating to help pay hosting costs and keeping the site fee to use.

Product

Screener Valuation Tools Company Research Financial Statements Historical Fundamentals

Company

About Contact

Legal

Terms Privacy

© 2026 Rare Elephants. All data is provided for informational and educational purposes only — it is not investment, legal, or tax advice, and we make no guarantee of its accuracy or completeness. Always verify figures independently before making a decision.